{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["106(1)"],"submitter":["Kong Q"],"pubmed_abstract":["<h4>Purpose</h4>Whether patients suffering liver oligometastases from pancreatic ductal adenocarcinoma (LOPDA) should undergo surgical treatment remains controversial.<h4>Methods</h4>PubMed and Embase databases were systematically reviewed until 2023 June. Survival data were collected from the Kaplan-Meier curves. Safety and survival were evaluated using primary outcomes such as 1-year, 3-year, and 5-year survival rates, and 30-day mortality and morbidity. A subgroup meta-analysis was conducted to compare survival rates post-synchronous resection and resection post-neoadjuvant chemotherapy in LOPDA.<h4>Results</h4>Our analysis of 15 studies involving 1,818 patients (surgical group, 648 and nonsurgical group, 1,170) indicates that radical hepatectomy for LOPDA notably improved 1-year (odds "],"journal":["Annals of surgical treatment and research"],"pagination":["51-60"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10774701"],"repository":["biostudies-literature"],"pubmed_title":["Radical resection benefits patients suffering pancreatic ductal adenocarcinoma with liver oligometastases."],"pmcid":["PMC10774701"],"pubmed_authors":["Li H","Kong Q","Chen Z","Teng F"],"additional_accession":[]},"is_claimable":false,"name":"Radical resection benefits patients suffering pancreatic ductal adenocarcinoma with liver oligometastases.","description":"<h4>Purpose</h4>Whether patients suffering liver oligometastases from pancreatic ductal adenocarcinoma (LOPDA) should undergo surgical treatment remains controversial.<h4>Methods</h4>PubMed and Embase databases were systematically reviewed until 2023 June. Survival data were collected from the Kaplan-Meier curves. Safety and survival were evaluated using primary outcomes such as 1-year, 3-year, and 5-year survival rates, and 30-day mortality and morbidity. A subgroup meta-analysis was conducted to compare survival rates post-synchronous resection and resection post-neoadjuvant chemotherapy in LOPDA.<h4>Results</h4>Our analysis of 15 studies involving 1,818 patients (surgical group, 648 and nonsurgical group, 1,170) indicates that radical hepatectomy for LOPDA notably improved 1-year (odds ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan","modification":"2025-04-04T13:58:48.313Z","creation":"2025-04-04T13:58:48.313Z"},"accession":"S-EPMC10774701","cross_references":{"pubmed":["38205094"],"doi":["10.4174/astr.2024.106.1.51"]}}